| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endovascular Procedures | 35 | 2025 | 608 | 6.350 |
Why?
|
| Peripheral Arterial Disease | 23 | 2024 | 163 | 6.310 |
Why?
|
| Lower Extremity | 19 | 2024 | 152 | 5.590 |
Why?
|
| Blood Vessel Prosthesis Implantation | 26 | 2025 | 297 | 4.420 |
Why?
|
| Aortic Aneurysm, Abdominal | 16 | 2025 | 236 | 3.960 |
Why?
|
| Vascular Surgical Procedures | 17 | 2022 | 251 | 3.450 |
Why?
|
| Endarterectomy, Carotid | 8 | 2024 | 91 | 2.890 |
Why?
|
| Ischemia | 13 | 2024 | 199 | 2.490 |
Why?
|
| Treatment Outcome | 65 | 2025 | 5284 | 2.260 |
Why?
|
| Carotid Stenosis | 7 | 2022 | 104 | 2.210 |
Why?
|
| Risk Factors | 61 | 2025 | 4984 | 2.140 |
Why?
|
| Limb Salvage | 11 | 2024 | 69 | 2.090 |
Why?
|
| Retrospective Studies | 69 | 2025 | 6071 | 1.950 |
Why?
|
| Time Factors | 48 | 2025 | 3617 | 1.910 |
Why?
|
| Intermittent Claudication | 6 | 2020 | 53 | 1.900 |
Why?
|
| Vascular Patency | 15 | 2024 | 135 | 1.820 |
Why?
|
| Databases, Factual | 29 | 2024 | 813 | 1.450 |
Why?
|
| Arteriovenous Shunt, Surgical | 9 | 2020 | 43 | 1.410 |
Why?
|
| Hospital Mortality | 12 | 2024 | 841 | 1.330 |
Why?
|
| Risk Assessment | 31 | 2025 | 1921 | 1.320 |
Why?
|
| Saphenous Vein | 5 | 2020 | 47 | 1.260 |
Why?
|
| Upper Extremity | 7 | 2022 | 49 | 1.260 |
Why?
|
| Stents | 8 | 2025 | 461 | 1.240 |
Why?
|
| Aged | 56 | 2025 | 13416 | 1.240 |
Why?
|
| Postoperative Complications | 22 | 2025 | 1202 | 1.220 |
Why?
|
| Vascular System Injuries | 4 | 2021 | 20 | 1.210 |
Why?
|
| Blood Vessel Prosthesis | 10 | 2025 | 215 | 1.180 |
Why?
|
| Femoral Artery | 7 | 2019 | 101 | 1.140 |
Why?
|
| Carotid Artery Diseases | 5 | 2022 | 63 | 1.130 |
Why?
|
| Vascular Diseases | 3 | 2020 | 75 | 1.070 |
Why?
|
| Ticlopidine | 2 | 2017 | 45 | 1.050 |
Why?
|
| Patient Selection | 9 | 2020 | 464 | 1.050 |
Why?
|
| Aged, 80 and over | 30 | 2025 | 5128 | 1.040 |
Why?
|
| Male | 65 | 2025 | 27739 | 1.030 |
Why?
|
| Humans | 85 | 2025 | 59360 | 1.000 |
Why?
|
| Kidney Failure, Chronic | 5 | 2020 | 206 | 0.980 |
Why?
|
| Insulins | 2 | 2023 | 15 | 0.970 |
Why?
|
| Renal Dialysis | 9 | 2020 | 189 | 0.970 |
Why?
|
| Elective Surgical Procedures | 7 | 2020 | 112 | 0.950 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2017 | 211 | 0.930 |
Why?
|
| Female | 63 | 2025 | 30705 | 0.920 |
Why?
|
| Computed Tomography Angiography | 3 | 2024 | 113 | 0.920 |
Why?
|
| Aortic Aneurysm, Thoracic | 5 | 2025 | 105 | 0.910 |
Why?
|
| Wounds, Penetrating | 2 | 2021 | 23 | 0.900 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2024 | 44 | 0.870 |
Why?
|
| Ultrasonography, Doppler, Duplex | 5 | 2021 | 49 | 0.860 |
Why?
|
| Drug-Eluting Stents | 1 | 2024 | 51 | 0.860 |
Why?
|
| Reoperation | 12 | 2025 | 272 | 0.860 |
Why?
|
| Vena Cava, Inferior | 2 | 2021 | 28 | 0.840 |
Why?
|
| Cardiovascular Agents | 1 | 2024 | 98 | 0.830 |
Why?
|
| Middle Aged | 46 | 2025 | 16317 | 0.820 |
Why?
|
| Aneurysm | 2 | 2022 | 56 | 0.820 |
Why?
|
| Multivariate Analysis | 16 | 2021 | 902 | 0.810 |
Why?
|
| United States | 26 | 2025 | 7390 | 0.790 |
Why?
|
| Comorbidity | 14 | 2024 | 1078 | 0.790 |
Why?
|
| Diabetes Mellitus | 3 | 2023 | 515 | 0.770 |
Why?
|
| Patient Care Team | 1 | 2024 | 326 | 0.760 |
Why?
|
| Iliac Vein | 1 | 2021 | 9 | 0.740 |
Why?
|
| Quality Indicators, Health Care | 1 | 2024 | 332 | 0.720 |
Why?
|
| Abdominal Injuries | 1 | 2021 | 30 | 0.720 |
Why?
|
| Radiography, Interventional | 2 | 2018 | 72 | 0.720 |
Why?
|
| Financial Support | 1 | 2020 | 4 | 0.700 |
Why?
|
| Surgeons | 2 | 2020 | 161 | 0.700 |
Why?
|
| Gift Giving | 1 | 2020 | 8 | 0.690 |
Why?
|
| Health Care Sector | 1 | 2020 | 20 | 0.690 |
Why?
|
| Vascular Grafting | 5 | 2019 | 39 | 0.680 |
Why?
|
| Chi-Square Distribution | 14 | 2018 | 409 | 0.680 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2019 | 1 | 0.670 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 141 | 0.650 |
Why?
|
| Angioplasty, Balloon | 2 | 2024 | 57 | 0.650 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2018 | 275 | 0.650 |
Why?
|
| Stroke | 6 | 2022 | 1127 | 0.630 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 90 | 0.620 |
Why?
|
| Pneumonectomy | 1 | 2019 | 96 | 0.620 |
Why?
|
| Predictive Value of Tests | 6 | 2024 | 1025 | 0.610 |
Why?
|
| Multimodal Imaging | 2 | 2018 | 66 | 0.610 |
Why?
|
| Patient Compliance | 1 | 2021 | 349 | 0.600 |
Why?
|
| Prosthesis-Related Infections | 2 | 2018 | 33 | 0.590 |
Why?
|
| Femoral Vein | 3 | 2019 | 18 | 0.580 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 56 | 0.580 |
Why?
|
| Blood Loss, Surgical | 2 | 2018 | 57 | 0.580 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 74 | 0.580 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2018 | 70 | 0.570 |
Why?
|
| Blood Transfusion | 2 | 2017 | 150 | 0.540 |
Why?
|
| Postoperative Hemorrhage | 1 | 2017 | 37 | 0.540 |
Why?
|
| Prosthesis Design | 7 | 2025 | 209 | 0.520 |
Why?
|
| Odds Ratio | 12 | 2020 | 745 | 0.520 |
Why?
|
| Asymptomatic Diseases | 6 | 2020 | 46 | 0.520 |
Why?
|
| Angioplasty | 2 | 2022 | 51 | 0.490 |
Why?
|
| Kaplan-Meier Estimate | 7 | 2019 | 396 | 0.490 |
Why?
|
| Aspirin | 1 | 2016 | 166 | 0.470 |
Why?
|
| Wounds, Gunshot | 3 | 2020 | 52 | 0.460 |
Why?
|
| Hemorrhage | 1 | 2016 | 260 | 0.450 |
Why?
|
| Venous Thrombosis | 2 | 2014 | 110 | 0.450 |
Why?
|
| Catheterization, Peripheral | 3 | 2019 | 46 | 0.440 |
Why?
|
| Medicare | 4 | 2023 | 598 | 0.430 |
Why?
|
| Patient Readmission | 6 | 2019 | 420 | 0.420 |
Why?
|
| Logistic Models | 11 | 2018 | 1232 | 0.420 |
Why?
|
| Aortic Aneurysm | 1 | 2014 | 81 | 0.420 |
Why?
|
| Smoking | 1 | 2018 | 826 | 0.410 |
Why?
|
| Propensity Score | 6 | 2019 | 144 | 0.400 |
Why?
|
| Coronary Stenosis | 1 | 2012 | 30 | 0.380 |
Why?
|
| Vascular Access Devices | 2 | 2024 | 15 | 0.380 |
Why?
|
| Connective Tissue | 1 | 2011 | 12 | 0.380 |
Why?
|
| Critical Illness | 7 | 2018 | 325 | 0.380 |
Why?
|
| Cysts | 1 | 2011 | 40 | 0.370 |
Why?
|
| Device Removal | 3 | 2018 | 64 | 0.370 |
Why?
|
| Graft Occlusion, Vascular | 6 | 2021 | 62 | 0.370 |
Why?
|
| Recurrence | 5 | 2020 | 603 | 0.370 |
Why?
|
| Aortic Rupture | 3 | 2021 | 54 | 0.350 |
Why?
|
| Registries | 9 | 2021 | 801 | 0.350 |
Why?
|
| Length of Stay | 7 | 2020 | 775 | 0.350 |
Why?
|
| Coronary Artery Bypass | 1 | 2012 | 274 | 0.340 |
Why?
|
| Wound Healing | 3 | 2016 | 174 | 0.320 |
Why?
|
| Age Factors | 6 | 2020 | 1504 | 0.320 |
Why?
|
| Endoleak | 4 | 2023 | 39 | 0.310 |
Why?
|
| Hematoma | 2 | 2019 | 68 | 0.310 |
Why?
|
| Severity of Illness Index | 10 | 2020 | 1479 | 0.300 |
Why?
|
| Firearms | 2 | 2019 | 54 | 0.290 |
Why?
|
| Disease-Free Survival | 4 | 2018 | 228 | 0.280 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2012 | 687 | 0.270 |
Why?
|
| Clinical Decision-Making | 4 | 2020 | 146 | 0.260 |
Why?
|
| Drug Administration Schedule | 2 | 2017 | 283 | 0.250 |
Why?
|
| New England | 3 | 2019 | 267 | 0.240 |
Why?
|
| Vena Cava Filters | 2 | 2014 | 23 | 0.230 |
Why?
|
| Hospitals, High-Volume | 1 | 2024 | 32 | 0.220 |
Why?
|
| Interdisciplinary Communication | 1 | 2024 | 103 | 0.220 |
Why?
|
| Diffusion of Innovation | 1 | 2024 | 56 | 0.220 |
Why?
|
| Vascular Calcification | 1 | 2024 | 22 | 0.220 |
Why?
|
| Survival Rate | 2 | 2018 | 802 | 0.220 |
Why?
|
| Follow-Up Studies | 3 | 2023 | 2337 | 0.220 |
Why?
|
| Paclitaxel | 1 | 2024 | 91 | 0.220 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2024 | 131 | 0.220 |
Why?
|
| Carotid Artery, Internal | 2 | 2022 | 66 | 0.220 |
Why?
|
| Operative Time | 3 | 2020 | 76 | 0.210 |
Why?
|
| Spinal Cord Ischemia | 1 | 2023 | 16 | 0.210 |
Why?
|
| History, 21st Century | 1 | 2024 | 162 | 0.210 |
Why?
|
| Myocardial Infarction | 2 | 2024 | 862 | 0.210 |
Why?
|
| Health Services Needs and Demand | 1 | 2024 | 203 | 0.210 |
Why?
|
| Aortography | 2 | 2022 | 55 | 0.200 |
Why?
|
| Prevalence | 2 | 2024 | 1252 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 705 | 0.190 |
Why?
|
| Adult | 10 | 2024 | 15669 | 0.190 |
Why?
|
| Fluoroscopy | 2 | 2018 | 62 | 0.190 |
Why?
|
| Popliteal Artery | 2 | 2019 | 26 | 0.190 |
Why?
|
| Surgical Wound Infection | 2 | 2019 | 110 | 0.190 |
Why?
|
| Ligation | 1 | 2021 | 33 | 0.190 |
Why?
|
| Patient Acuity | 1 | 2021 | 19 | 0.180 |
Why?
|
| Watchful Waiting | 1 | 2021 | 24 | 0.180 |
Why?
|
| Emergency Service, Hospital | 2 | 2019 | 1021 | 0.180 |
Why?
|
| Tertiary Care Centers | 1 | 2021 | 100 | 0.170 |
Why?
|
| Heart Diseases | 2 | 2020 | 206 | 0.170 |
Why?
|
| AIDS-Associated Nephropathy | 1 | 2020 | 9 | 0.170 |
Why?
|
| Disclosure | 1 | 2020 | 51 | 0.170 |
Why?
|
| Conflict of Interest | 1 | 2020 | 36 | 0.170 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 98 | 0.170 |
Why?
|
| Serum Albumin, Human | 1 | 2019 | 6 | 0.160 |
Why?
|
| Hypoalbuminemia | 1 | 2019 | 7 | 0.160 |
Why?
|
| Axillary Artery | 1 | 2019 | 7 | 0.160 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 1561 | 0.160 |
Why?
|
| Chronic Disease | 2 | 2020 | 716 | 0.160 |
Why?
|
| Constriction, Pathologic | 2 | 2024 | 112 | 0.160 |
Why?
|
| Forearm | 1 | 2019 | 19 | 0.160 |
Why?
|
| Secondary Prevention | 1 | 2020 | 151 | 0.160 |
Why?
|
| Aorta, Abdominal | 1 | 2019 | 58 | 0.160 |
Why?
|
| Proportional Hazards Models | 3 | 2018 | 674 | 0.160 |
Why?
|
| Wrist | 1 | 2019 | 33 | 0.160 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 206 | 0.160 |
Why?
|
| Prospective Studies | 3 | 2023 | 3067 | 0.150 |
Why?
|
| Personnel Selection | 1 | 2019 | 50 | 0.150 |
Why?
|
| Radiation Exposure | 1 | 2018 | 16 | 0.150 |
Why?
|
| General Surgery | 1 | 2021 | 191 | 0.150 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 174 | 0.150 |
Why?
|
| Reference Values | 1 | 2019 | 326 | 0.150 |
Why?
|
| Exercise Test | 1 | 2020 | 242 | 0.150 |
Why?
|
| Patient-Specific Modeling | 1 | 2018 | 10 | 0.150 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2018 | 71 | 0.150 |
Why?
|
| Intracranial Aneurysm | 1 | 2022 | 345 | 0.150 |
Why?
|
| Anesthesia, Local | 1 | 2018 | 20 | 0.150 |
Why?
|
| Obesity, Morbid | 1 | 2019 | 92 | 0.150 |
Why?
|
| Anesthesia, General | 1 | 2018 | 43 | 0.150 |
Why?
|
| Respiratory Tract Diseases | 1 | 2018 | 34 | 0.150 |
Why?
|
| Thrombectomy | 1 | 2020 | 208 | 0.150 |
Why?
|
| Disability Evaluation | 1 | 2019 | 199 | 0.150 |
Why?
|
| Heparin | 1 | 2018 | 111 | 0.140 |
Why?
|
| Models, Cardiovascular | 1 | 2018 | 76 | 0.140 |
Why?
|
| New York City | 2 | 2014 | 75 | 0.140 |
Why?
|
| Physicians | 1 | 2022 | 435 | 0.140 |
Why?
|
| Perioperative Period | 1 | 2017 | 19 | 0.140 |
Why?
|
| Faculty, Medical | 1 | 2019 | 192 | 0.140 |
Why?
|
| Transfusion Reaction | 1 | 2017 | 44 | 0.130 |
Why?
|
| Young Adult | 3 | 2021 | 4267 | 0.130 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 166 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 1526 | 0.130 |
Why?
|
| Protective Factors | 1 | 2016 | 33 | 0.130 |
Why?
|
| Anemia | 1 | 2017 | 119 | 0.130 |
Why?
|
| Sex Factors | 2 | 2020 | 935 | 0.120 |
Why?
|
| Thoracic Outlet Syndrome | 1 | 2015 | 5 | 0.120 |
Why?
|
| Subclavian Vein | 1 | 2015 | 11 | 0.120 |
Why?
|
| Ribs | 1 | 2015 | 4 | 0.120 |
Why?
|
| Child, Preschool | 3 | 2020 | 1782 | 0.120 |
Why?
|
| Health Status | 4 | 2019 | 424 | 0.120 |
Why?
|
| Resuscitation Orders | 1 | 2015 | 48 | 0.120 |
Why?
|
| Patient Preference | 1 | 2015 | 78 | 0.120 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 179 | 0.120 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 452 | 0.120 |
Why?
|
| Anticoagulants | 1 | 2018 | 477 | 0.110 |
Why?
|
| Blood Flow Velocity | 1 | 2014 | 68 | 0.110 |
Why?
|
| Area Under Curve | 1 | 2014 | 141 | 0.110 |
Why?
|
| Endarterectomy | 1 | 2013 | 18 | 0.110 |
Why?
|
| Smoking Cessation | 1 | 2019 | 541 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2014 | 185 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2021 | 746 | 0.110 |
Why?
|
| ROC Curve | 1 | 2014 | 266 | 0.110 |
Why?
|
| Angiography | 1 | 2013 | 146 | 0.110 |
Why?
|
| Skin Transplantation | 1 | 2014 | 155 | 0.110 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 132 | 0.100 |
Why?
|
| HIV Infections | 1 | 2020 | 913 | 0.100 |
Why?
|
| Surgical Flaps | 1 | 2014 | 110 | 0.100 |
Why?
|
| Veins | 2 | 2023 | 61 | 0.090 |
Why?
|
| Edema | 1 | 2011 | 43 | 0.090 |
Why?
|
| Residence Characteristics | 1 | 2012 | 215 | 0.090 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 95 | 0.090 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 178 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2012 | 290 | 0.080 |
Why?
|
| Quality of Life | 1 | 2016 | 1137 | 0.080 |
Why?
|
| Injury Severity Score | 2 | 2020 | 101 | 0.080 |
Why?
|
| Patient Discharge | 3 | 2018 | 489 | 0.080 |
Why?
|
| North America | 2 | 2019 | 106 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 735 | 0.070 |
Why?
|
| Boston | 2 | 2018 | 246 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 657 | 0.070 |
Why?
|
| Heart Failure | 1 | 2014 | 853 | 0.060 |
Why?
|
| Incidence | 2 | 2020 | 1237 | 0.060 |
Why?
|
| Disease Progression | 2 | 2020 | 1122 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2020 | 1283 | 0.060 |
Why?
|
| Infant | 2 | 2020 | 1486 | 0.060 |
Why?
|
| Biomarkers | 2 | 2019 | 1306 | 0.050 |
Why?
|
| Aorta, Thoracic | 1 | 2023 | 81 | 0.050 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2022 | 42 | 0.050 |
Why?
|
| Paraparesis | 1 | 2021 | 9 | 0.050 |
Why?
|
| Retreatment | 1 | 2021 | 46 | 0.050 |
Why?
|
| Workload | 1 | 2021 | 118 | 0.040 |
Why?
|
| Embolectomy | 1 | 2020 | 15 | 0.040 |
Why?
|
| Dependent Ambulation | 1 | 2019 | 2 | 0.040 |
Why?
|
| Child | 2 | 2020 | 4174 | 0.040 |
Why?
|
| Patient Care Planning | 1 | 2020 | 84 | 0.040 |
Why?
|
| Mobility Limitation | 1 | 2019 | 47 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 1 | 2020 | 90 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2020 | 107 | 0.040 |
Why?
|
| Arteries | 1 | 2020 | 76 | 0.040 |
Why?
|
| Polytetrafluoroethylene | 1 | 2019 | 18 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 61 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 375 | 0.040 |
Why?
|
| Bibliometrics | 1 | 2019 | 27 | 0.040 |
Why?
|
| Consent Forms | 1 | 2019 | 15 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2019 | 119 | 0.040 |
Why?
|
| Authorship | 1 | 2019 | 23 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2020 | 180 | 0.040 |
Why?
|
| Prosthesis Failure | 1 | 2019 | 71 | 0.040 |
Why?
|
| Adolescent | 2 | 2020 | 5824 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 184 | 0.040 |
Why?
|
| Career Mobility | 1 | 2019 | 62 | 0.040 |
Why?
|
| Intraoperative Care | 1 | 2018 | 36 | 0.040 |
Why?
|
| Choice Behavior | 1 | 2019 | 78 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 317 | 0.040 |
Why?
|
| Safety-net Providers | 1 | 2018 | 29 | 0.040 |
Why?
|
| Equipment Design | 1 | 2019 | 329 | 0.040 |
Why?
|
| Punctures | 1 | 2018 | 56 | 0.040 |
Why?
|
| After-Hours Care | 1 | 2017 | 7 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2018 | 131 | 0.040 |
Why?
|
| Hematocrit | 1 | 2017 | 32 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 741 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2017 | 133 | 0.030 |
Why?
|
| Medicaid | 1 | 2020 | 334 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2021 | 683 | 0.030 |
Why?
|
| Kidney | 1 | 2018 | 416 | 0.030 |
Why?
|
| Phlebography | 1 | 2015 | 43 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2017 | 239 | 0.030 |
Why?
|
| Decision Making | 1 | 2019 | 395 | 0.030 |
Why?
|
| Decompression, Surgical | 1 | 2015 | 61 | 0.030 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2015 | 85 | 0.030 |
Why?
|